← Leaderboards
Ming Hu
Washington State University
$8,685,593
Attributed
$12,812,654
Total exposure
10
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2M · FY2005–25$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$12,263,645 · 9
FDA$549,009 · 1
By mechanism
R01$11,057,689 · 6
R41$854,954 · 2
U01$549,009 · 1
R21$351,002 · 1
Top collaborators
- Stuart J Wong6 shared
- Ming You6 shared
- Rashim Singh3 shared
- Sebastian Polak2 shared
- Bing-Yan Wang2 shared
- Xiaoqiang Wang2 shared
- Feng Zhang2 shared
- Tsz Yan Clement Chan1 shared
Others in their field
Top investigators on “Prevent”
- Lawrence Corey · Fred Hutchinson Cancer Center$609,181,782
- Jeffrey P Krischer · University Of South Florida$605,511,231
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$530,065,238
- Bambra Strokes · Ppd Development Lp$526,656,217
- Judith S. Currier · University Of California Los Angeles$499,311,118
- David Heimbrook · Leidos Biomedical Research, Inc.$496,394,926
Research focus
PreventIn VitroPharmaceutical PreparationsDrug KineticsDesignGlucuronosyltransferaseIn VivoEnzymesAnimal ModelMalignant NeoplasmsTissuesPathway InteractionsBiological AvailabilityIntestinesBiologicalGlucuronidesDoseBeta-GlucuronidaseClinical TrialsClinical ResearchGenisteinLeadSuccessOrgan
Grant awards (38)
Systemic and gastrointestinal targeted CDPK1 inhibitors for cryptosporidiosis$812,603
R01 · FY2025 · AI
Elucidating High Oral Fluid Exposure Mechanisms of Buprenorphine to Reduce Dental Caries$710,155
R01 · FY2025 · DE · contact PI
Developing PBPK-model based mechanistic IVIVC for PLGA implants$249,645
U01 · FY2025 · FD
Developing PBPK-model based mechanistic IVIVC for PLGA implants$299,364
U01 · FY2024 · FD
Mechanistic and Pharmacokinetic Studies of Classical Chinese Formula Xiao Chai Hu Tang Against Irinotecan-Induced Gut Toxicities$187,050
R01 · FY2024 · CA · contact PI
Elucidating High Oral Fluid Exposure Mechanisms of Buprenorphine to Reduce Dental Caries$1,434,060
R01 · FY2023 · DE · contact PI
Genetic Biocontainment Switch to Improve the Safety of Drug Detoxifying Bacteria in Preventing Chemotherapy-induced Diarrhea$399,999
R41 · FY2023 · CA
Mechanistic and Pharmacokinetic Studies of Classical Chinese Formula Xiao Chai Hu Tang Against Irinotecan-Induced Gut Toxicities$192,957
R01 · FY2023 · CA · contact PI
Inhibition of Oral Tumorigenesis by Antitumor B$471,422
R01 · FY2022 · CA
Mechanistic and Pharmacokinetic Studies of Classical Chinese Formula Xiao Chai Hu Tang Against Irinotecan-Induced Gut Toxicities$192,957
R01 · FY2022 · CA · contact PI
Development of Drug Detoxifying Bacteria for Chemotherapy Induced Gut Injury$55,000
R41 · FY2022 · CA
Inhibition of Oral Tumorigenesis by Antitumor B$403,481
R01 · FY2021 · CA
Development of Drug Detoxifying Bacteria for Chemotherapy Induced Gut Injury$399,955
R41 · FY2021 · CA
Mechanistic and Pharmacokinetic Studies of Classical Chinese Formula Xiao Chai Hu Tang Against Irinotecan-Induced Gut Toxicities$196,895
R01 · FY2021 · CA · contact PI
Mechanistic and Pharmacokinetic Studies of Classical Chinese Formula Xiao Chai Hu Tang Against Irinotecan-Induced Gut Toxicities$208,582
R01 · FY2020 · CA · contact PI
Inhibition of Oral Tumorigenesis by Antitumor B$183,047
R01 · FY2020 · CA
Inhibition of Oral Tumorigenesis by Antitumor B$481,383
R01 · FY2019 · CA
Inhibition of Oral Tumorigenesis by Antitumor B$504,001
R01 · FY2018 · CA
Disposition of Flavonoids via Glucuronidation, Critical Role of Efflux Transporte$526,577
R01 · FY2017 · GM · contact PI
Inhibition of Oral Tumorigenesis by Antitumor B$525,681
R01 · FY2017 · CA
Disposition of Flavonoids via Glucuronidation, Critical Role of Efflux Transporte$478,213
R01 · FY2016 · GM · contact PI
Disposition of Flavonoids via Glucuronidation, Critical Role of Efflux Transporte$93,411
R01 · FY2016 · GM · contact PI
Disposition of Flavonoids via Glucuronidation, Critical Role of Efflux Transporte$398,273
R01 · FY2015 · GM · contact PI
Disposition of Flavonoids via Glucuronidation, Critical Role of Efflux Transporte$54,668
R01 · FY2015 · GM · contact PI
Disposition of Flavonoids via Glucuronidation, Critical Role of Efflux Transporte$419,918
R01 · FY2014 · GM · contact PI
Disposition of Flavonoids via Metabolic Interplay$388,548
R01 · FY2012 · GM · contact PI
Disposition of Flavonoids via Metabolic Interplay$388,652
R01 · FY2011 · GM · contact PI
Disposition of Flavonoids via Metabolic Interplay$259,875
R01 · FY2010 · GM · contact PI
Disposition of Flavonoids via Metabolic Interplay$145,472
R01 · FY2010 · GM · contact PI
Disposition of Flavonoids via Metabolic Interplay$262,500
R01 · FY2009 · GM · contact PI
Disposition of Flavanoids via Enteric Recycling$134,840
R01 · FY2007 · GM · contact PI
Disposition of Flavanoids via Enteric Recycling$142,003
R01 · FY2006 · GM · contact PI
Absorption and Metabolism of Isoflavones$211,613
R01 · FY2005 · CA
Absorption and Metabolism of Isoflavones$211,613
R01 · FY2004 · CA
Absorption and Metabolism of Isoflavones$206,522
R01 · FY2003 · CA
Absorption and Metabolism of Isoflavones$230,717
R01 · FY2002 · CA
DISPOSITION OF GINKGO FLAVONOIDS VIA RECYCLING$2,002
R21 · FY2001 · AT
DISPOSITION OF GINKGO FLAVONOIDS VIA RECYCLING$349,000
R21 · FY2000 · AT